CN104418948B - A method of preparing polypeptide drugs - Google Patents

A method of preparing polypeptide drugs Download PDF

Info

Publication number
CN104418948B
CN104418948B CN201310410636.9A CN201310410636A CN104418948B CN 104418948 B CN104418948 B CN 104418948B CN 201310410636 A CN201310410636 A CN 201310410636A CN 104418948 B CN104418948 B CN 104418948B
Authority
CN
China
Prior art keywords
fmoc
resin
gly
diapep277
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310410636.9A
Other languages
Chinese (zh)
Other versions
CN104418948A (en
Inventor
宓鹏程
潘俊锋
马亚平
袁建成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybio Pharmaceutical Co Ltd
Original Assignee
Hybio Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybio Pharmaceutical Co Ltd filed Critical Hybio Pharmaceutical Co Ltd
Priority to CN201310410636.9A priority Critical patent/CN104418948B/en
Publication of CN104418948A publication Critical patent/CN104418948A/en
Application granted granted Critical
Publication of CN104418948B publication Critical patent/CN104418948B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a kind of methods for preparing polypeptide drugs DiaPep277, include: Fmoc-Asp (OtBu)-OH and resin P being coupled, Fmoc-Asp (OtBu)-P is obtained;By Fmoc-Asp (OtBu)-P synthesis in solid state by the way of being coupled one by one, DiaPep277-P is obtained;DiaPep277-P is cracked, the thick peptide of DiaPep277 is obtained.

Description

A method of preparing polypeptide drugs
Technical field
The present invention relates to a kind of methods for preparing polypeptide drugs, in particular to the preparation method of DiaPep277.
Background technique
DiaPep277 is derived from one section in human heat shock protein 60 (HSP60) sequence peptide fragment containing 24 amino acid. The structure of DiaPep277 is as follows:
H-Val-Leu-Gly-Gly-Gly-Val-Ala-Leu-Leu-Arg-Val-Ile-Pro-Ala-Leu-Asp- Ser-Leu-Thr-Pro-Ala-Asn-Glu-Asp-OH。
Research has shown that DiaPep277 can adjust immune system, makes islet cells damage and protects insulin secretion Function.Therefore, the treatment zone that DiaPep277 is autoimmune diabetes patient carrys out substantive breakthrough, and can be used as The preventive usage of this onset diabetes people at highest risk.This drug can significantly improve the existence matter of type-1 diabetes mellitus patient Amount, delays or prevents the generation of various complication, to improve the life expectancy of patient.
Summary of the invention
For the small peptide containing 24 amino acid, since solid phase method is there are easy to operate, solvent usage amount is small, be easy to from The advantages that dynamicization, therefore solid phase sequence coupling is often carried out using conventional protected amino acid and is synthesized.But through analyzing After the peptide chain of DiaPep277, the inventors discovered that, it is some special which there is a situation where, a large amount of hydrophobic group is (especially N-terminal) and-Gly-Gly-Gly- structure presence can make synthesis there are bigger difficulty.If using conventional Fmoc-Gly- OH raw material is easy the impurity etc. of the generation ± Gly in synthesis-Gly-Gly-Gly- structure.
It is an object of the invention to solve above-mentioned difficulties using special amino acid starting material, the purity and receipts of thick peptide are improved Rate.
The present invention provides a kind of method for preparing polypeptide drugs DiaPep277 comprising the steps of:
1) using a kind of resin P as carrier, Fmoc-Asp (OtBu)-OH and resin is coupled, Fmoc-Asp is obtained (OtBu)-P;
2) using Fmoc-Asp (OtBu)-P as raw material, solid phase is carried out with other amino acid starting materials by the way of being coupled one by one Synthesis, obtains DiaPep277-P;
3) DiaPep277-P is cracked, obtains the thick peptide of DiaPep277;
Wherein Fmoc is 9-fluorenylmethyloxycarbonyl, is connected with amino or is connected with the nitrogen-atoms on the connected carbon atom of carboxyl,
The synthesis material that Asp-Ser structure uses in the mode being wherein coupled one by one described in step 2) is Fmoc-Asp (OtBu)-Ser(ψMe,MePro)-OH is a pseudo proline dipeptides, so that serine is protected into five-membered ring, structure is as follows:
The synthesis material that wherein-Gly-Gly-Gly- structure uses is Fmoc- (Hmb) Gly-OH, Fmoc- (Dmb) Gly- One or both of OH, Fmoc-Gly- (Dmb) Gly-OH or Fmoc-Gly- (Hmb) Gly-OH.
Preferably, the method for the present invention further includes the steps that purifying DiaPep277.
Specific embodiment
Abbreviation used in the present invention and its meaning are described as follows:
Herein, " substitution degree " refers to that the quantity of the resin-carried substance of unit quantity, unit are " mmol/g ".
Herein, as without opposite explanation, then the reaction carries out at normal temperatures and pressures.
Wide in range, preferred, preferred and most preferred definition and range in the present invention can be combined with each other.
" peptide " refers to the coupled product obtained similarly by the Fmoc solid phase synthesis process in Peptide systhesis in the present invention.
The vector resin is not particularly limited, as long as it has the active site that can be reacted with the carboxyl in substance And it is not reacted with the other groups in the substance.The vector resin is preferably two class of 2-CTC resin or Wang Shuzhi, tree Rouge substitution degree is 0.2-1.0mmol/g, preferably 0.3-0.8mmol/g, more preferably 0.4-0.6mmol/g.
The structure of Wang Shuzhi class used in the present invention is as follows:
The structure of 2-CTC resinae used is as follows:
WhereinIt represents the rest part of resin structure and the part is not involved in reaction.
Above two resin is available commercially (Tianjin Nankai Hecheng S&T Co., Ltd.) or by method known to document Preparation.
In a specific embodiment, can according to before the dosage of resin, reaction substitution degree and required reaction after Substitution degree select the dosage of Fmoc- amino acid-OH, usually can be with the molal quantity of the functional group of amino acid couplings on resin 1-5 equivalent, preferred 2-4 equivalent, more preferable 2.5-3.5 equivalent wherein can be with the functional group mole of amino acid couplings on resin Number is the product of weight resin and substitution degree.
The solvent is, such as, but not limited to, DMF, DCM, DMSO, NMP, THF, ethyl acetate, methanol, ether etc. and The mixed liquor (for example, the two volume ratio is 1:1) of its any mixture, preferably DMF, DCM or DMF and DCM.
Coupling, which prepares peptide resin, can be used the reality of Fmoc solid phase synthesis process known to technical staff in Peptides Synthesis It is existing, such as may refer to document Fmoc Solid Phase Peptide Synthesis:A Practical Approach, W.C.Chan, Peter D.White write, March 2,2000 (ISBN-10:0199637245), Britain Oxford University Press。
The washing of resin and swelling can be used in coupling and realize that any reagent of the purpose carries out, preferably DMF.
Described be coupled in solid phase reaction column carries out.Solid phase reaction column is not particularly limited, can be that this purpose can be achieved Any solid phase reaction column.
Preferably, by step 1) -2) in carboxyl in substance activate, activation preferably carries out in ice-water bath.Activation Agent is preferably DIPEA or DIC.
It further include that one is added thereto wherein after amino acid Fmoc-Asp (OtBu)-OH is coupled on vector resin Kind of confining liquid removes the step of excessive unreacted group in resin, to avoid its in next step coupling reaction with it is other to It is coupled substance reaction and forms by-product, and the step of removing confining liquid be added.When the vector resin is 2-CTC resin When, the confining liquid being added is preferably methanol;When the vector resin is Wang Shuzhi, the confining liquid being added is preferably mole Than the acetic anhydride and pyridine for 1:1.
Coupling preferably carries out in the presence of coupling agent, and the coupling agent is preferably DIC, A or its combination, Huo Zhewei DIPEA, A, B or its combination, wherein A is HOBt or HOAt, one of B PyBOP, PyAOP, HATU, HBTU and TBTU;Example Such as, the coupling agent in step 1) is HOBt/DIC.
(the OtBu)-Ser of Fmoc-Asp described in step 2) (ψMe,MePro) coupling system of-OH is HATU/HOAt/ One of DIPEA, PyBOP/HOBt/DIPEA or TBTU/HOBt/DIPEA.
The synthesis material that-Gly-Gly-Gly- structure uses in the mode being coupled one by one described in step 2) is Fmoc- (Hmb) one in Gly-OH, Fmoc- (Dmb) Gly-OH, Fmoc-Gly- (Dmb) Gly-OH or Fmoc-Gly- (Hmb) Gly-OH Kind or two kinds;Preferably, the raw material is one kind selected from Fmoc- (Hmb) Gly-OH and Fmoc- (Dmb) Gly-OH, Yi Jixuan From one kind of Fmoc-Gly- (Dmb) Gly-OH and Fmoc-Gly- (Hmb) Gly-OH.
The coupling system of Gly synthesis material described in step 2) is DIC/HOAt, HATU/BOAt/DIPEA or PyBOP/ One of HOBt/DIPEA.
In addition, it is usually 1-6 hours, preferably 2-5 hours that every kind of substance, which carries out the time of coupling reaction,;Pressure is preferably normal Pressure, can also properly increase or reduced pressure (such as 0.01-1.5 atmospheric pressure) under carry out;Temperature be preferably room temperature (refer to 20 ± 5 DEG C), it (such as 0-50 DEG C) can also be carried out at a temperature of properly increasing or is reduced.
In coupling process, detection agent used can be any reagent that can determine that the reaction end, preferably ninhydrin.
The reagent for removing Fmoc can be any reagent that the purpose can be achieved, preferably DBLK (i.e. 20% piperidines/DMF).
The deprotection reaction time is usually 5-30 minutes, preferably 10-20 minutes;Pressure is preferably normal pressure, can also be appropriate It is carried out under the pressure (such as 0.01-1.5 atmospheric pressure) increased or decreased;Temperature is preferably room temperature (referring to 20 ± 5 DEG C), can also be suitable (such as 0-50 DEG C) carries out at a temperature of increasing or decreasing.
The cracking preferably carries out at room temperature and atmospheric pressure, can also properly increase or reduced temperature and pressure under into Row.
The mixed solvent of lytic reagent TFA, tri isopropyl silane (TIS) and water in step 3), wherein mixed solvent Proportion are as follows: TFA volume ratio is 85-90%, and the volume ratio of tri isopropyl silane is 1-5%, and the volume ratio of water is 1-5%, three The sum of be 100%.
In a specific embodiment, lytic reagent described in step 3) is TFA:TIS:H2O=90:5:5 (V:V).
Preferably, the method for preparing DiaPep277 compound further includes the steps that purifying DiaPep277.Purifying can be used Fast protecting etc. is carried out conventionally used for the method for purifying DiaPep277.
In the present invention, it is preferable that be purified by recrystallization method and carry out, i.e., by dissolving DiaPep277 with solvent, so The crystal of DiaPep277 is precipitated afterwards and realizes.
In a specific embodiment, purify DiaPep277 the step of by with good solvent dissolve DiaPep277, Then poor solvent is added the crystal of DiaPep277 is precipitated and realizes." good solvent " refers to right at room temperature and atmospheric pressure herein The solubility of DiaPep277 is greater than the solvent of 90 weight %, preferably greater than 95 weight %, more preferably greater than 99 weight %;It is " bad Solvent " refer at room temperature and atmospheric pressure to the solubility of DiaPep277 less than 10 weight %, preferably smaller than 5%, more preferably less than 1% solvent.
Recrystallization preferably carry out at room temperature and atmospheric pressure, can also properly increase or reduced pressure under carry out.Recrystallization It can be used and realized conventionally used for this purpose all devices.
Preferably, it is purified by RP-HPLC (for example, chromatographic column is reverse phase C18 column) purifying, freeze-drying obtains DiaPep277, purity are greater than 98%.
Referring to embodiment the present invention is described in detail, it should be appreciated that following embodiments are intended to illustrate, not constitute to the present invention Limitation.Compound or reagent used in the following embodiment can be bought by commercial sources, or pass through those skilled in the art Known conventional method is prepared;Used laboratory apparatus can be bought by commercial sources.
Embodiment
Embodiment one: substitution degree is the preparation of Fmoc-Asp (the OtBu)-Wang Resin of 0.4mmol/g
The Wang resin 120g (120mmol) that substitution degree is 1.0mmol/g is weighed, is added in solid phase reaction column, is washed with DMF Wash 2 times, after DMF swellable resins 30 minutes, take 98.7g Fmoc-Asp (OtBu)-OH, 38.9g HOBt, 36.3g DIC, 2.93g DMAP is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added in solid phase reaction column, reacts at room temperature 2h.Reaction After washed 4 times with DMF, DCM is washed 2 times.Then 189.8g pyridine is added and 245.04g acetic anhydride mixed liquor closes resin 6h.It is washed 4 times with DMF, after DCM is washed 2 times, methanol is collected concentration and drained, and obtains Fmoc-Asp (OtBu)-Wang resin, examines Survey substitution degree is 0.402mmol/g.
Embodiment two: substitution degree is the preparation of Fmoc-Asp (the OtBu)-Wang Resin of 0.6mmol/g
The Wang resin 120g (120mmol) that substitution degree is 1.0mmol/g is weighed, is added in solid phase reaction column, is washed with DMF Wash 2 times, after DMF swellable resins 30 minutes, take 138.2g Fmoc-Asp (OtBu)-OH, 54.5g HOBt, 50.8g DIC, 4.1g DMAP is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added in solid phase reaction column, reacts at room temperature 2h.Reaction knot Shu Houyong DMF is washed 4 times, and DCM is washed 2 times.Then 189.8g pyridine is added and 245.04g acetic anhydride mixed liquor closes resin 6h. It is washed 4 times with DMF, after DCM is washed 2 times, methanol is collected concentration and drained, and obtains Fmoc-Asp (OtBu)-Wang resin, detection is replaced Dai Du is 0.603mmol/g.
Embodiment three: substitution degree is the preparation of Fmoc-Asp (the OtBu)-Wang Resin of 0.5mmol/g
The Wang resin 120g (120mmol) that substitution degree is 1.0mmol/g is weighed, is added in solid phase reaction column, is washed with DMF Wash 2 times, after DMF swellable resins 30 minutes, take 118.4g Fmoc-Asp (OtBu)-OH, 46.7g HOBt, 43.6g DIC, 3.5g DMAP is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added in solid phase reaction column, reacts at room temperature 2h.Reaction knot Shu Houyong DMF is washed 4 times, and DCM is washed 2 times.Then 189.8g pyridine is added and 245.04g acetic anhydride mixed liquor closes resin 6h. It is washed 4 times with DMF, after DCM is washed 2 times, methanol is collected concentration and drained, and obtains Fmoc-Asp (OtBu)-Wang resin, detection is replaced Dai Du is 0.505mmol/g.
Example IV: substitution degree is the preparation of Fmoc-Asp (the OtBu)-CTC Resin of 0.4mmol/g
The 2-CTC resin 150g (150mmol) that substitution degree is 1.0mmol/g is weighed, is added in solid phase reaction column, is used DMF is washed 2 times, after DMF swellable resins 30 minutes, takes 29.6g (72mmol) Fmoc-Asp (OtBu)-OH to be dissolved with DMF, ice After 13.9g (108mmol) DIPEA activation is added under water-bath, it is added in the above-mentioned reaction column equipped with resin, after reacting 5min, then Secondary addition 9.3g (72mmol) DIPEA reacts at room temperature 60min.182mL anhydrous methanol is added in reaction solution and closes 30min.With DMF is washed 3 times, and DCM is washed 3 times, and methanol is collected concentration and drained, and obtains Fmoc-Asp (OtBu)-CTC resin, and detection substitution degree is 0.407mmol/g。
Embodiment five: substitution degree is the preparation of Fmoc-Asp (the OtBu)-CTC Resin of 0.6mmol/g
The 2-CTC resin 150g (150mmol) that substitution degree is 1.0mmol/g is weighed, is added in solid phase reaction column, is used DMF is washed 2 times, after DMF swellable resins 30 minutes, 44.4g (108mmol) Fmoc-Asp (OtBu)-OH is taken to be dissolved with DMF, After 20.9g (162mmol) DIPEA activation is added under ice-water bath, it is added in the above-mentioned reaction column equipped with resin, after reacting 5min, 13.9g (108mmol) DIPEA is added again, reacts at room temperature 60min.The closing of 182mL anhydrous methanol is added in reaction solution 30min.It is washed 3 times with DMF, DCM is washed 3 times, and methanol is collected concentration and drained, and obtains Fmoc-Asp (OtBu)-CTC resin, is detected Substitution degree is 0.601mmol/g.
Embodiment six: substitution degree is the preparation of Fmoc-Asp (the OtBu)-CTC Resin of 0.5mmol/g
The 2-CTC resin 150g (150mmol) that substitution degree is 1.0mmol/g is weighed, is added in solid phase reaction column, is used DMF is washed 2 times, after DMF swellable resins 30 minutes, takes 37.0g (90mmol) Fmoc-Asp (OtBu)-OH to be dissolved with DMF, ice After 17.4g (135mmol) DIPEA activation is added under water-bath, it is added in the above-mentioned reaction column equipped with resin, after reacting 5min, then Secondary addition 11.6g (90mmol) DIPEA reacts at room temperature 60min.182mL anhydrous methanol is added in reaction solution and closes 30min. It is washed 3 times with DMF, DCM is washed 3 times, and methanol is collected concentration and drained, and obtains Fmoc-Asp (OtBu)-CTC resin, detects substitution degree For 0.508mmol/g.
The preparation of seven: DiaPep277-Wang resin of embodiment
Weigh Fmoc-Asp (the OtBu)-Wang resin 198.0g that substitution degree in embodiment three is 0.505mmol/g (100mmol) is added in solid phase reaction column, is washed 2 times with DMF, after DMF swellable resins 30 minutes, is removed with DBLK Fmoc protection, is then washed 6 times with DMF, detects color of resin with ninhydrin method, and resin has color, indicates that Fmoc has been removed.It takes 127.7g Fmoc-Glu (OtBu)-OH (300mmol), 48.6g HOBt (360mmol), be dissolved in volume ratio be 1:1 DCM and DMF mixed solution is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, and room temperature is anti- It answers 2 hours.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, It then indicates reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria is sentenced suitable for subsequent content with ninhydrin method detection Disconnected reaction end.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide Sequence is sequentially completed Fmoc-Asn (Trt)-OH, Fmoc-Ala-OH, Fmoc-Pro-OH, Fmoc-Thr (tBu)-OH, Fmoc- The coupling of Leu-OH.Take 166.7g Fmoc-Asp (OtBu)-Ser (ψMe,MePro)-OH(300mmol;Purchased from gill biochemistry), 114.1g HATU (300mmol), 49.0g HOAt (360mmol) are dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, ice It is added in solid phase reaction column after 104.3ml DIPEA (600mmol) activation 3min is added under water-bath, is detected and judged with ninhydrin method Reaction end, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, need to be coupled anti-again It answers 1 hour.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide sequence, It is sequentially completed Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Pro-OH, Fmoc-Ile-OH, Fmoc-Val-OH, Fmoc-Arg (pbf) coupling of-OH, Fmoc-Leu-OH, Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Val-OH.Weigh 130.1g Fmoc- (Hmb) Gly-OH (300mmol), 114.1g HATU (300mmol), 49.0g HOAt (360mmol), is dissolved in volume ratio Solid phase is added after 104.3ml DIPEA (600mmol) activation 3min is added for DCM the and DMF mixed solution of 1:1, under ice-water bath In reaction column, reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, Then indicate that reaction not exclusively, needs coupling reaction 1 hour again.It repeats above-mentioned removing Fmoc protection and corresponding amino acid couplings is added Step is sequentially completed the coupling of Fmoc- (Hmb) Gly-OH, Fmoc- (Hmb) Gly-OH according to DiaPep277 main chain peptide sequence.Claim It takes 106.1g Fmoc-Leu-OH (300mmol), 48.6g HOBt (360mmol), it is mixed to be dissolved in DCM and DMF that volume ratio is 1:1 Solution is closed, is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, room temperature reaction 2 is small When.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that Reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria detects judgement reaction suitable for subsequent content with ninhydrin method Terminal.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, it is complete according to DiaPep277 main chain peptide sequence At the coupling of Fmoc-Val-OH.It is collected and is concentrated with methanol after reaction, resin vacuum is dried overnight, and weighing obtains DiaPep277-Wang resin 451.6g.
The preparation of eight: DiaPep277-Wang resin of embodiment
Weigh Fmoc-Asp (the OtBu)-Wang resin 198.0g that substitution degree in embodiment three is 0.505mmol/g (100mmol) is added in solid phase reaction column, is washed 2 times with DMF, after DMF swellable resins 30 minutes, is removed with DBLK Fmoc protection, is then washed 6 times with DMF, detects color of resin with ninhydrin method, and resin has color, indicates that Fmoc has been removed.It takes 127.7g Fmoc-Glu (OtBu)-OH (300mmol), 48.6g HOBt (360mmol), be dissolved in volume ratio be 1:1 DCM and DMF mixed solution is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, and room temperature is anti- It answers 2 hours.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, It then indicates reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria is sentenced suitable for subsequent content with ninhydrin method detection Disconnected reaction end.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide Sequence is sequentially completed Fmoc-Asn (Trt)-OH, Fmoc-Ala-OH, Fmoc-Pro-OH, Fmoc-Thr (tBu)-OH, Fmoc- The coupling of Leu-OH.Take 166.7g Fmoc-Asp (OtBu)-Ser (ψMe,MePro)-OH(300mmol)、156.1g PyBOP (300mmol), 48.6g HOBt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added under ice-water bath 104.3ml DIPEA (600mmol) is added in solid phase reaction column after activating 3min, judges reaction end with ninhydrin method detection, If resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again. The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings are added, according to DiaPep277 main chain peptide sequence, is sequentially completed Fmoc-Leu-OH、Fmoc-Ala-OH、Fmoc-Pro-OH、Fmoc-Ile-OH、Fmoc-Val-OH、Fmoc-Arg(pbf)-OH、 The coupling of Fmoc-Leu-OH, Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Val-OH.Weigh 134.3gFmoc- (Dmb) Gly-OH (300mmol), 156.1g PyBOP (300mmol), 48.6g HOBt (360mmol), being dissolved in volume ratio is 1:1's Solid phase reaction column is added after 104.3ml DIPEA (600mmol) activation 3min is added under ice-water bath in DCM and DMF mixed solution In, reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that Reaction not exclusively, needs coupling reaction 1 hour again.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, According to DiaPep277 main chain peptide sequence, it is sequentially completed the coupling of Fmoc- (Dmb) Gly-OH, Fmoc- (Dmb) Gly-OH.It weighs 106.1g Fmoc-Leu-OH (300mmol), 48.6g HOBt (360mmol) are dissolved in DCM and DMF that volume ratio is 1:1 and mix Solution is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, reacts at room temperature 2 hours. Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that anti- Coupling reaction 1 hour again not exclusively should be needed, this judgment criteria detects judgement reaction eventually with ninhydrin method suitable for subsequent content Point.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings are added, according to DiaPep277 main chain peptide sequence, completes The coupling of Fmoc-Val-OH.It is collected and is concentrated with methanol after reaction, resin vacuum is dried overnight, and weighing obtains DiaPep277-Wang resin 455.6g.
The preparation of nine: DiaPep277-Wang resin of embodiment
Weigh Fmoc-Asp (the OtBu)-Wang resin 198.0g that substitution degree in embodiment three is 0.505mmol/g (100mmol) is added in solid phase reaction column, is washed 2 times with DMF, after DMF swellable resins 30 minutes, is removed with DBLK Fmoc protection, is then washed 6 times with DMF, detects color of resin with ninhydrin method, and resin has color, indicates that Fmoc has been removed.It takes 127.7g Fmoc-Glu (OtBu)-OH (300mmol), 48.6g HOBt (360mmol), be dissolved in volume ratio be 1:1 DCM and DMF mixed solution is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, and room temperature is anti- It answers 2 hours.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, It then indicates reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria is sentenced suitable for subsequent content with ninhydrin method detection Disconnected reaction end.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide Sequence is sequentially completed Fmoc-Asn (Trt)-OH, Fmoc-Ala-OH, Fmoc-Pro-OH, Fmoc-Thr (tBu)-OH, Fmoc- The coupling of Leu-OH.Take 166.7g Fmoc-Asp (OtBu)-Ser (ψMe,MePro)-OH(300mmol)、96.3g TBTU (300mmol), 48.6g HOBt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added under ice-water bath 104.3ml DIPEA (600mmol) is added in solid phase reaction column after activating 3min, judges reaction end with ninhydrin method detection, If resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again. The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings are added, according to DiaPep277 main chain peptide sequence, is sequentially completed Fmoc-Leu-OH、Fmoc-Ala-OH、Fmoc-Pro-OH、Fmoc-Ile-OH、Fmoc-Val-OH、Fmoc-Arg(pbf)-OH、 The coupling of Fmoc-Leu-OH, Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Val-OH.Weigh 134.3gFmoc- (Dmb) Gly-OH (300mmol), 49.0g HOAt (360mmol) are dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, ice-water bath It is added in solid phase reaction column after lower addition 56.3ml DIC (360mmol) activation 3min, judgement reaction is detected eventually with ninhydrin method Point, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs again coupling reaction 1 small When.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide sequence, successively Complete the coupling of Fmoc- (Dmb) Gly-OH, Fmoc- (Dmb) Gly-OH.106.1g Fmoc-Leu-OH (300mmol) is weighed, 48.6g HOBt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1,56.3ml DIC is added under ice-water bath (360mmol) is added in solid phase reaction column after activating 3min, reacts at room temperature 2 hours.Reaction end is judged with ninhydrin method detection, If resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again, This judgment criteria judges reaction end suitable for subsequent content with ninhydrin method detection.It repeats above-mentioned removing Fmoc protection and adds The step of entering corresponding amino acid couplings completes the coupling of Fmoc-Val-OH according to DiaPep277 main chain peptide sequence.After reaction It is collected and is concentrated with methanol, resin vacuum is dried overnight, and weighing obtains DiaPep277-Wang resin 458.1g.
The preparation of ten: DiaPep277-Wang resin of embodiment
Weigh Fmoc-Asp (the OtBu)-Wang resin 198.0g that substitution degree in embodiment three is 0.505mmol/g (100mmol) is added in solid phase reaction column, is washed 2 times with DMF, after DMF swellable resins 30 minutes, is removed with DBLK Fmoc protection, is then washed 6 times with DMF, detects color of resin with ninhydrin method, and resin has color, indicates that Fmoc has been removed.It takes 127.7g Fmoc-Glu (OtBu)-OH (300mmol), 48.6g HOBt (360mmol), be dissolved in volume ratio be 1:1 DCM and DMF mixed solution is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, and room temperature is anti- It answers 2 hours.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, It then indicates reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria is sentenced suitable for subsequent content with ninhydrin method detection Disconnected reaction end.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide Sequence is sequentially completed Fmoc-Asn (Trt)-OH, Fmoc-Ala-OH, Fmoc-Pro-OH, Fmoc-Thr (tBu)-OH, Fmoc- The coupling of Leu-OH.Take 166.7gFmoc-Asp (OtBu)-Ser (ψMe,MePro)-OH(300mmol)、96.3g TBTU (300mmol), 48.6g HOBt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added under ice-water bath 104.3ml DIPEA (600mmol) is added in solid phase reaction column after activating 3min, judges reaction end with ninhydrin method detection, If resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again. The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings are added, according to DiaPep277 main chain peptide sequence, is sequentially completed Fmoc-Leu-OH、Fmoc-Ala-OH、Fmoc-Pro-OH、Fmoc-Ile-OH、Fmoc-Val-OH、Fmoc-Arg(pbf)-OH、 The coupling of Fmoc-Leu-OH, Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Val-OH.Weigh 134.3gFmoc- (Dmb) Gly-OH (300mmol), 49.0g HOAt (360mmol) are dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, ice-water bath It is added in solid phase reaction column after lower addition 56.3ml DIC (360mmol) activation 3min, judgement reaction is detected eventually with ninhydrin method Point, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs again coupling reaction 1 small When.With DBLK removing Fmoc protection, is then washed 6 times with DMF, detect color of resin with ninhydrin method, resin has color, indicates Fmoc has been removed.151.4g Fmoc-Gly- (Dmb) Gly-OH (purchased from Merck), 49.0g HOAt (360mmol) are weighed, it is molten It is added after 56.3ml DIC (360mmol) activation 3min is added under DCM the and DMF mixed solution that volume ratio is 1:1, ice-water bath In solid phase reaction column, reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin Colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again.With DBLK removing Fmoc protection, then washed 6 times with DMF, Color of resin is detected with ninhydrin method, resin has color, indicates that Fmoc has been removed.Weigh 106.1g Fmoc-Leu-OH (300mmol), 48.6g HOBt (360mmol) are dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, are added under ice-water bath 56.3ml DIC (360mmol) is added in solid phase reaction column after activating 3min, reacts at room temperature 2 hours.Sentenced with ninhydrin method detection Disconnected reaction end, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, need to be coupled again Reaction 1 hour, this judgment criteria judge reaction end suitable for subsequent content with ninhydrin method detection.Repeat above-mentioned removing The step of Fmoc is protected and corresponding amino acid couplings are added, according to DiaPep277 main chain peptide sequence, completes the idol of Fmoc-Val-OH Connection.It is collected and is concentrated with methanol after reaction, resin vacuum is dried overnight, and weighing obtains DiaPep277-Wang resin 448.3g。
The preparation of 11: DiaPep277-CTC resin of embodiment
Weigh Fmoc-Asp (the OtBu)-CTC resin 196.9g that substitution degree in embodiment six is 0.508mmol/g (100mmol) is added in solid phase reaction column, is washed 2 times with DMF, after DMF swellable resins 30 minutes, is removed with DBLK Fmoc protection, is then washed 6 times with DMF, detects color of resin with ninhydrin method, and resin has color, indicates that Fmoc has been removed.It takes 127.7g Fmoc-Glu (OtBu)-OH (300mmol), 48.6g HOBt (360mmol), be dissolved in volume ratio be 1:1 DCM and DMF mixed solution is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, and room temperature is anti- It answers 2 hours.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, It then indicates reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria is sentenced suitable for subsequent content with ninhydrin method detection Disconnected reaction end.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide Sequence is sequentially completed Fmoc-Asn (Trt)-OH, Fmoc-Ala-OH, Fmoc-Pro-OH, Fmoc-Thr (tBu)-OH, Fmoc- The coupling of Leu-OH.Take 166.7g Fmoc-Asp (OtBu)-Ser (ψMe,MePro)-OH(300mmol)、114.1g HATU (300mmol), 49.0g HOAt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added under ice-water bath 104.3ml DIPEA (600mmol) is added in solid phase reaction column after activating 3min, judges reaction end with ninhydrin method detection, If resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again. The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings are added, according to DiaPep277 main chain peptide sequence, is sequentially completed Fmoc-Leu-OH、Fmoc-Ala-OH、Fmoc-Pro-OH、Fmoc-Ile-OH、Fmoc-Val-OH、Fmoc-Arg(pbf)-OH、 The coupling of Fmoc-Leu-OH, Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Val-OH.Weigh 130.1g Fmoc- (Hmb) Gly-OH (300mmol), 49.0g HOAt (360mmol) are dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, ice-water bath It is added in solid phase reaction column after lower addition 56.3ml DIC (360mmol) activation 3min, judgement reaction is detected eventually with ninhydrin method Point, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs again coupling reaction 1 small When.With DBLK removing Fmoc protection, is then washed 6 times with DMF, detect color of resin with ninhydrin method, resin has color, indicates Fmoc has been removed.Weigh 147.2g Fmoc-Gly- (Hmb) Gly-OH (purchased from Merck), 156.1g PyBOP (300mmol), 48.6g HOBt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1,104.3ml is added under ice-water bath DIPEA (600mmol) is added in solid phase reaction column after activating 3min, reaction end is judged with ninhydrin method detection, if resin It is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again.It is de- with DBLK It except Fmoc is protected, is then washed 6 times with DMF, detects color of resin with ninhydrin method, resin has color, indicates that Fmoc has been removed. It weighs 106.1g Fmoc-Leu-OH (300mmol), 48.6g HOBt (360mmol), is dissolved in the DCM and DMF that volume ratio is 1:1 Mixed solution is added in solid phase reaction column, room temperature reaction 2 after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath Hour.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin develops the color, then table Show reaction not exclusively, need coupling reaction 1 hour again, this judgment criteria is anti-with ninhydrin method detection judgement suitable for subsequent content Answer terminal.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide sequence, Complete the coupling of Fmoc-Val-OH.It is collected and is concentrated with methanol after reaction, resin vacuum is dried overnight, and weighing obtains DiaPep277-Wang resin 449.3g.
The preparation of 12: DiaPep277-CTC resin of embodiment
Weigh Fmoc-Asp (the OtBu)-CTC resin 196.9g that substitution degree in embodiment six is 0.508mmol/g (100mmol) is added in solid phase reaction column, is washed 2 times with DMF, after DMF swellable resins 30 minutes, is removed with DBLK Fmoc protection, is then washed 6 times with DMF, detects color of resin with ninhydrin method, and resin has color, indicates that Fmoc has been removed.It takes 127.7g Fmoc-Glu (OtBu)-OH (300mmol), 48.6g HOBt (360mmol), be dissolved in volume ratio be 1:1 DCM and DMF mixed solution is added in solid phase reaction column after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath, and room temperature is anti- It answers 2 hours.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, It then indicates reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria is sentenced suitable for subsequent content with ninhydrin method detection Disconnected reaction end.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide Sequence is sequentially completed Fmoc-Asn (Trt)-OH, Fmoc-Ala-OH, Fmoc-Pro-OH, Fmoc-Thr (tBu)-OH, Fmoc- The coupling of Leu-OH.Take 166.7g Fmoc-Asp (OtBu)-Ser (ψMe,MePro)-OH(300mmol)、156.1g PyBOP (300mmol), 48.6g HOBt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added under ice-water bath 104.3ml DIPEA (600mmol) is added in solid phase reaction column after activating 3min, judges reaction end with ninhydrin method detection, If resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again. The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings are added, according to DiaPep277 main chain peptide sequence, is sequentially completed Fmoc-Leu-OH、Fmoc-Ala-OH、Fmoc-Pro-OH、Fmoc-Ile-OH、Fmoc-Val-OH、Fmoc-Arg(pbf)-OH、 The coupling of Fmoc-Leu-OH, Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Val-OH.Weigh 147.2g Fmoc-Gly- (Hmb) Gly-OH (300mmol), 114.1g HATU (300mmol), 49.0g HOAt (360mmol), being dissolved in volume ratio is 1:1 DCM and DMF mixed solution, solid phase reaction column is added after 104.3ml DIPEA (600mmol) activation 3min is added under ice-water bath In, reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that Reaction not exclusively, needs coupling reaction 1 hour again.With DBLK removing Fmoc protection, is then washed 6 times with DMF, examined with ninhydrin method Color of resin is surveyed, resin has color, indicates that Fmoc has been removed.Weigh 134.3g Fmoc- (Dmb) Gly-OH, 114.1g HATU (300mmol), 49.0g HOAt (360mmol) is dissolved in DCM the and DMF mixed solution that volume ratio is 1:1, is added under ice-water bath 104.3ml DIPEA (600mmol) is added in solid phase reaction column after activating 3min, judges reaction end with ninhydrin method detection, If resin is colorless and transparent, then it represents that fully reacting;Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again. With DBLK removing Fmoc protection, is then washed 6 times with DMF, detect color of resin with ninhydrin method, resin has color, indicates Fmoc has been removed.It weighs 106.1g Fmoc-Leu-OH (300mmol), 48.6g HOBt (360mmol), being dissolved in volume ratio is 1: Solid phase reaction column is added after 56.3ml DIC (360mmol) activation 3min is added under ice-water bath in 1 DCM and DMF mixed solution In, it reacts at room temperature 2 hours.Reaction end is judged with ninhydrin method detection, if resin is colorless and transparent, then it represents that fully reacting; Resin colour developing, then it represents that reaction not exclusively, needs coupling reaction 1 hour again, this judgment criteria is suitable for subsequent content with indenes three The detection of ketone method judges reaction end.The step of repeating above-mentioned removing Fmoc protection and corresponding amino acid couplings be added, according to DiaPep277 main chain peptide sequence, completes the coupling of Fmoc-Val-OH.It is collected and is concentrated with methanol after reaction, resin vacuum is dry Overnight, weighing obtains DiaPep277-Wang resin 450.7g.
The preparation of the thick peptide of embodiment 13: DiaPep277
The peptide resin prepared in Example seven to 12 is placed in cracking reaction wherein, is added with the ratio of 10ml/g resin Lytic reagent (TFA:TIS: water=90:5:5 (V/V)), is stirred at room temperature 2h.Reactant is filtered with sand core funnel, collects filtrate, tree Rouge is washed 3 times with a small amount of TFA again, is concentrated under reduced pressure after merging filtrate.The anhydrous ether precipitating of frost is added, is washed with anhydrous ether 3 times, vacuum drying obtains white powder solid, the i.e. thick peptide of DiaPep277, and weight yield is 98.6%~103.9%.HPLC is pure Degree is greater than 55%.Single impurity is less than 5%.
The preparation of 14: DiaPep277 fine peptide of embodiment
It weighs in embodiment 13 after any thick peptide 4000ml water dissolution of 80.0g DiaPep277, using Waters 2545RP-HPLC system, wavelength 230nm, chromatographic column are 50 × 250mm reverse phase C18 column, conventional 0.2%TFA/ acetonitrile mobile phase Purpose peak fraction is collected in purifying, obtains purity greater than 98.5% fine peptide.Rotary evaporation concentration, freeze-drying obtain DiaPep277 fine peptide 23.5g, RP-HPLC purity are greater than 98.5%.

Claims (17)

1. a kind of method for preparing polypeptide drugs DiaPep277 comprising the steps of:
1) using a kind of resin P as carrier, Fmoc-Asp (OtBu)-OH and resin is coupled, Fmoc-Asp (OtBu)-P is obtained;
2) using Fmoc-Asp (OtBu)-P as raw material, solid phase conjunction is carried out with other amino acid starting materials by the way of being coupled one by one At obtaining DiaPep277-P;
3) DiaPep277-P is cracked, obtains the thick peptide of DiaPep277;
Wherein Fmoc is 9-fluorenylmethyloxycarbonyl, is connected with amino or is connected with the nitrogen-atoms on the connected carbon atom of carboxyl,
The synthesis material that Asp-Ser structure uses in the mode being wherein coupled one by one described in step 2) is Fmoc-Asp (OtBu)-Ser(ψMe,MePro)-OH is a pseudo proline dipeptides, so that serine is protected into five-membered ring, structure is as follows:
The synthesis material that wherein-Gly-Gly-Gly- structure uses for Fmoc- (Hmb) Gly-OH, Fmoc- (Dmb) Gly-OH, One or both of Fmoc-Gly- (Dmb) Gly-OH or Fmoc-Gly- (Hmb) Gly-OH;
Wherein Glu, Asn, Ala, Pro, Thr, Leu, Ile, Arg use synthesis material be respectively Fmoc-Glu (OtBu)-OH, Fmoc-Asn(Trt)-OH、Fmoc-Ala-OH、Fmoc-Pro-OH、Fmoc-Thr(tBu)-OH、Fmoc-Leu-OH、Fmoc- Ile-OH,Fmoc-Arg(pbf)-OH;
(the OtBu)-Ser of Fmoc-Asp described in step 2) (ψMe,MePro) coupling system of-OH be HATU/HOAt/DIPEA or PyBOP/HOBt/DIPEA;
The coupling system of Gly synthesis material described in step 2) is DIC/HOAt or HATU/HOAt/DIPEA.
2. method of claim 1, further include the steps that purifying DiaPep277, be purified by recrystallization method or HPLC and into Row.
3. method for claim 2, HPLC is reversed-phase HPLC.
4. the method for claim 1 wherein steps 1) -3) carry out at room temperature and atmospheric pressure;Step 1) -2) coupling reaction exist It is carried out in solid phase reaction column.
5. the method for claim 1 wherein the resin P is 2-CTC resin or Wang Shuzhi;The wherein substitution degree of the resin P For 0.2-1.0mmol/g.
6. method for claim 5, wherein the substitution degree of the resin P is 0.3-0.8mmol/g.
7. method for claim 5, wherein the substitution degree of the resin P is 0.4-0.6mmol/g.
8. the method for claim 1 wherein-Gly-Gly-Gly- structure uses in the mode being coupled one by one described in step 2) Synthesis material is one kind selected from Fmoc- (Hmb) Gly-OH and Fmoc- (Dmb) Gly-OH, and is selected from Fmoc-Gly- (Dmb) One kind of Gly-OH and Fmoc-Gly- (Hmb) Gly-OH.
9. the method for claim 1 wherein the coupling agent in step 1) is HOBt/DIC.
10. the method for claim 1 wherein carried out to the washing of resin and swelling using DMF in coupling;By step 1) -2) in Carboxyl in substance is activated.
11. method for claim 10, activation carries out in ice-water bath;Activator is DIPEA or DIC.
12. the method for claim 1 wherein steps 1) -2) in the reagent of removing Fmoc be DBLK;The deprotection reaction time is 5- 30 minutes.
13. the method for claim 12, wherein the deprotection reaction time is 10-20 minutes.
14. the method for claim 1 wherein the mixed solvent of lytic reagent TFA, tri isopropyl silane and water in step 3), The wherein proportion of mixed solvent are as follows: TFA volume ratio is 85-90%, and the volume ratio of tri isopropyl silane is 1-5%, the volume of water Than for 1-5%, the sum of three is 100%.
15. the method for claim 1 wherein the lytic reagent in step 3) is TFA:TIS:H2O volume ratio=90:5:5.
16. also being wrapped the method for claim 1 wherein after amino acid Fmoc-Asp (OtBu)-OH is coupled on vector resin It includes and the step of a kind of confining liquid removes excessive unreacted group in resin is added thereto.
17. the method for claim 16, when the vector resin is 2-CTC resin, the confining liquid being added is methanol;Work as institute State vector resin be Wang Shuzhi when, the confining liquid being added is the acetic anhydride and pyridine that molar ratio is 1:1.
CN201310410636.9A 2013-09-10 2013-09-10 A method of preparing polypeptide drugs Expired - Fee Related CN104418948B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310410636.9A CN104418948B (en) 2013-09-10 2013-09-10 A method of preparing polypeptide drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310410636.9A CN104418948B (en) 2013-09-10 2013-09-10 A method of preparing polypeptide drugs

Publications (2)

Publication Number Publication Date
CN104418948A CN104418948A (en) 2015-03-18
CN104418948B true CN104418948B (en) 2019-08-16

Family

ID=52969136

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310410636.9A Expired - Fee Related CN104418948B (en) 2013-09-10 2013-09-10 A method of preparing polypeptide drugs

Country Status (1)

Country Link
CN (1) CN104418948B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106916086A (en) * 2015-12-28 2017-07-04 深圳翰宇药业股份有限公司 A kind of solid phase synthesis process of paranitroanilinum modified polypeptide C-terminal
CN108383905A (en) * 2016-12-30 2018-08-10 江苏金斯瑞生物科技有限公司 A kind of preparation method of bivalirudin
CN112111001B (en) * 2019-06-19 2021-10-29 翰宇药业(武汉)有限公司 Method for synthesizing thymosin T alpha-1

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1175214A (en) * 1994-12-21 1998-03-04 耶达研究与发展有限公司 Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
CN101484467A (en) * 2006-05-10 2009-07-15 Bcn肽类股份有限公司 Method for synthesizing thymosins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010117725A2 (en) * 2009-04-06 2010-10-14 Novetide, Ltd. Production of peptides containing poly-gly sequences using fmoc chemistry

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1175214A (en) * 1994-12-21 1998-03-04 耶达研究与发展有限公司 Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
CN101484467A (en) * 2006-05-10 2009-07-15 Bcn肽类股份有限公司 Method for synthesizing thymosins

Also Published As

Publication number Publication date
CN104418948A (en) 2015-03-18

Similar Documents

Publication Publication Date Title
WO2018032521A1 (en) Method for synthesizing liraglutide
ES2592634T3 (en) Method for solid phase synthesis of liraglutide
CN102875655B (en) Linaclotide synthesis method
CN105384809B (en) A kind of method that segment method solid-liquid combination prepares Teriparatide
CN104387454B (en) A kind of method that fragment condensation prepares Triptorelin
CN102702320B (en) Method for preparing eptifibatide
WO2017097194A1 (en) Completely-solid-phase preparation method for carbetocin
WO2019113872A1 (en) Method for synthesizing linaclotide
CN104910269B (en) A method of synthesis Teriparatide
CN108047329A (en) A kind of preparation method of A Bapa peptides
CN103709243B (en) A method of preparing lixisenatide
CN104672320B (en) A kind of method of pure synthesis in solid state acetic acid redfish calcitonin
CN109280078B (en) A method of preparing Wella card peptide
CN104418948B (en) A method of preparing polypeptide drugs
CN104177490B (en) Method for preparing salmon calcitonin acetate by fragment condensation
CN104072603B (en) It is a kind of to synthesize for the method for degree Shandong peptide
CN104177491B (en) A kind of preparation method of Tesamorelin
CN109306366B (en) Method for synthesizing PT141
CN108383896A (en) A kind of method of segment method synthesis Goserelin
CN109180803A (en) Growth hormone release inhibiting hormone and preparation method thereof and pharmaceutical composition
CN111057129B (en) Preparation method and kit for synthesizing polypeptide containing two pairs of disulfide bonds, and preparation method of pramipexole
TW202404996A (en) Process for preparing a glp-1/glucagon dual agonist
CN107778355B (en) Method for synthesizing cetrorelix
CN103159850A (en) Preparation method of tetracosactide
WO2022141615A1 (en) Synthesis method for atosiban

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190816

CF01 Termination of patent right due to non-payment of annual fee